4TEEN4 begins trial of antibody therapy for cardiogenic shock - PharmaTimes First patient dosed in phase 1b/2a study of procizumab

#4TEEN4 #4TEEN4Pharmaceuticals #antibodytherapy #cardiogenicshock #phase1b/2astudy #procizumab #monoclonalantibody #PROCARD1trial #circulatingdipeptidylpeptidase3 #cDPP3 #cardiacdepressionfactor #shock #cDPP3inhibitor #angiotensinII #PROCARD1study
pharmatimes.com/news/4teen4-...